Genetics

Rare genetic disease may protect Ashkenazi Jews against TB

Scientists may have solved the question of why Ashkenazi Jews are significantly more susceptible to a rare genetic disorder known as Gaucher disease—and the answer may help settle the debate about whether they are less ...

Medications

Vaccine targeting latent TB enters clinical testing

Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The ...

Diseases, Conditions, Syndromes

Drugs to block angiogenesis could provide new treatment for TB

The body responds to tuberculosis infection by locking the bacterial offenders into tiny clusters of immune cells called granulomas, which are a hallmark of the disease. This containment strategy succeeds at first, but eventually ...

Immunology

Tuberculosis bacteria build 'edible' havens in immune cells

Bacteria that cause tuberculosis trick immune cells meant to destroy them into hiding and feeding them instead. This is the result of a study led by researchers from NYU Langone Medical Center and published online April 18 ...

Diseases, Conditions, Syndromes

Is tuberculosis making a comeback?

A year ago, Laura Hall felt tired all the time, was losing weight and had a bad cough.

Medical research

Team finds key to tuberculosis resistance

The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis have remained a ...

page 4 from 15